Free press releases distribution network?

Agency / Source: CCM International Ltd

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!



China Paclitaxel Injection Market Keeps A Stable Development Trend Finds CCM International - CCM published a report in July and forecast that China paclitaxel injection market will keep a stable development trend
China Paclitaxel Injection Market Keeps A Stable Development Trend Finds CCM International

 

PRZOOM - /newswire/ - Guangzhou, Guangdong, China, 2010/08/18 - CCM published a report in July and forecast that China paclitaxel injection market will keep a stable development trend.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

paclitaxel APIs (active pharmaceutical ingredients) was called off export rebate from China customs rebate list for new round of economy adjustment and partial reasons of environment protection consideration. Such act will affect export situation for China as one of the most important paclitaxel APIs countries, exporting about 14% of its domestic output according to the data from China Customs. However, the influence of this seems slim on China paclitaxel injection industry, and the market is still stable for a period, according to the survey of CCM International Limited, Chinese market research firm.

A market research report published later July by CCM International, reports that the cancellation of paclitaxel APIs export rebate may increase the supply in domestic market, but the injection market didn’t have sharp reaction so far. Actually, such APIs had some adjustments on export rebate in decade.

With regard to this injection market, policies and pharmaceutical distribution situation are the two key factors.

“By the end of Jun. 2010, many standards about environmental protection, production safety and application safety had been promulgated in China. Chinese government has strengthened pollution and quality control in paclitaxel industry to safeguard public health and eco-balance.” , told by CCM report. Healthcare reform policies issued by China government in 2009, which aim at relieving economic burden of patients, may increase anticancer drug market consumption.

Considering anticancer drug sales market, several substitutes grow rapidly, for instance docetaxel had higher growth rate comparing with pacalitaxel injection about 7% growth rate in 2009. Paclitaxel injection got slower growth rate in these years. The paclitaxel injection production values had reached USD67.21 million for China in 2009, account for 10% of total in world. And the injection domestic market shares were accounted for by domestic products, above 80%, the rest, mainly shared by Bristol-Myers Squibb (Taxol) and Mayne Pharma Pty Ltd (Anzatax). And both of production and sales value figures, will be higher in the next five years forecasted by CCM.

About this market share
Abraxis BioScience had launched his ABRAXANE in June 2009 in China, which will give sign for foreign companies that want to share this market, and totally boost paclitaxel injection industry. However, for these companies, the circulation and distribution platform situation should not be omitted. “Paclitaxel injection has to get into hospitals through the pharmaceutical distribution companies and medicine bidding and purchasing platforms.” Such platforms which less acquaintance in first-trail companies are highlighted parts in CCM report.

China paclitaxel injection industry has witnessed significant development from 2005-2009, it’s estimated to go far in the next five years, seems that more companies will be involved in the near future.

About CCM
CCM International, Ltd. (cnchemicals.com) is a world leader in China Market Data and Primary Intelligence. Since 2001, CCM has been providing Market Intelligence Data, Newsletters, Reports, and Dynamic Databases to Fortune 500 companies on five of seven continents.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Agency / Source: CCM International Ltd

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick PRZOOM - Press & Newswire Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma/BioTech/Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


China Paclitaxel Injection Market Keeps A Stable Development Trend Finds CCM International

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name PRZOOM - Press & Newswire and LINK as the source.
 
  For more information, please visit:
Is this your article? Activate ALL web links by Upgrading to Press Release PREMIUM Plan Now!
|
Contact: Viya Ding - CNChemicals.com 
+86 20-37616606 emarket3[.]cnchemicals.com
 
PRZOOM / PRTODAY - Newswire Today disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any CCM International Ltd securities in any jurisdiction including any other companies listed or named in this release.

Pharma/BioTech/Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!




Read Latest Press Releases From CCM International Ltd / Company Profile


Read Pharma/BioTech/Nutrition Most Recent Related Press Releases:

Ipsen Receives Positive CHMP Opinion for Approval of Xermelo® (telotristat Ethyl)
BD Receives FDA 510(k) Clearance for New Immunological Diagnostic System
Positive Phase III Results for Genentech’s Emicizumab in Hemophilia A Published in The New England Journal of Medicine
Somatuline® Autogel® 120 Mg Receives Japanese Approval for A New Indication for the Treatment of Gastro-entero-pancreatic Neuroendocrine Tumors
OTC Topical Drugs Market Size will Grow Profitably in the Near Future 2017-2025 Finds PMR
Bioinformatics Market Size to Expand at 20.4% CAGR through 2020 Reports Persistence Market Research
Australia Nitric Acid Market Expected to Reach at Value of $1.3B by 2024 End Says PMR
Commodity Chemicals Market Projected to be Resilient by 2020 Says Persistence Market Research
Cell Expansion Market Set to Garner Staggering Revenues by 2025 Reports PMR
Soft Tissue Sarcoma Treatment Market Revenue Predicted To Go Up by 2025 Finds Persistence Market Research

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
 
NewswireToday Celebrates 10 Years in Business
Find business coaching, life coaching, executive coaching and corporate coaching, best selling coaching books, ...



PREMIUM Members


Visit  NAKIVO, Inc.

Visit  BizJobs.com

Visit  MagLar, Inc.







 
  ©2017 PRZOOM — Limelon Advertising, Co.
Home | About PRZOOM | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneur newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today